Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ZIMMER BIOMET HOLDINGS, INC.

(ZBH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Piper Sandler Adjusts Zimmer Biomet Holdings PT to $185 From $195, Maintains Overweight Rating

11/05/2021 | 12:46pm EST


ę MT Newswires 2021
All news about ZIMMER BIOMET HOLDINGS, INC.
04:05pHealth Care Stocks Retreat This Afternoon
MT
11:39aZimmer Biomet's Spinoff Plan for Dental, Spine Businesses on Track with Regulatory Fili..
MT
09:08aZimmer Biomet Announces Filing of Form 10 Registration Statement in Connection with Pla..
PR
06:08aNeedham Trims Zimmer Biomet Holdings' Price Target to $155 From $158; Buy Rating Kept
MT
01/19Wells Fargo Cuts Zimmer Biomet Holdings to Underweight From Equalweight; Price Target t..
MT
01/11NORTH AMERICAN MORNING BRIEFING : Inflation, Rate -3-
DJ
01/10Zimmer Biomet Announces Webcast and Conference Call of Fourth Quarter 2021 Financial Re..
PR
01/10BTIG Downgrades Zimmer Biomet Holdings to Neutral From Buy
MT
01/10NORTH AMERICAN MORNING BRIEFING : Yields Rise, -3-
DJ
01/07Today on Wall Street: Is it legit?
More news
Analyst Recommendations on ZIMMER BIOMET HOLDINGS, INC.
More recommendations
Financials (USD)
Sales 2021 7 872 M - -
Net income 2021 839 M - -
Net Debt 2021 6 462 M - -
P/E ratio 2021 31,3x
Yield 2021 0,78%
Capitalization 25 600 M 25 600 M -
EV / Sales 2021 4,07x
EV / Sales 2022 3,76x
Nbr of Employees 20 000
Free-Float -
Chart ZIMMER BIOMET HOLDINGS, INC.
Duration : Period :
Zimmer Biomet Holdings, Inc. Technical Analysis Chart | ZBH | US98956P1021 | MarketScreener
Technical analysis trends ZIMMER BIOMET HOLDINGS, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 29
Last Close Price 122,54 $
Average target price 158,88 $
Spread / Average Target 29,7%
EPS Revisions
Managers and Directors
Bryan C. Hanson Chairman, President & Chief Executive Officer
Suketu P. Upadhyay Chief Financial Officer & Executive Vice President
Zeeshan Tariq Chief Information Officer & Senior Vice President
Nitin Goyal Chief Science, Technology & Innovation Officer
Ivan Tornos Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
ZIMMER BIOMET HOLDINGS, INC.-2.97%25 704
ABBOTT LABORATORIES-11.39%213 874
MEDTRONIC PLC2.57%142 671
BECTON, DICKINSON AND COMPANY4.93%75 243
HOYA CORPORATION-10.96%49 292
BAXTER INTERNATIONAL INC.0.17%43 055